Canada Plans 'Pause The Clock' Mechanism For Drug & Device Reviews
Executive Summary
Canada is proposing a clock stop in the drug review process to allow more time for the clarification of specific issues and help it meet its review deadlines.
You may also be interested in...
Pharma Fees To Soar In Canada Under Government Proposals
The licence evaluation fee Health Canada charges for drugs containing new active substances could jump by 76% under proposals by the government department, which says its current fees for pharma and medtech are outdated and need to change.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.